Analytical Overview: Seelos Therapeutics Inc (SEEL)’s Ratios Tell a Financial Story

Investors seeking to outperform the market often focus on hand-picking stocks. Selecting the right ones has proven to be a key factor in boosting wealth.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

As of close of business last night, Seelos Therapeutics Inc’s stock clocked out at $0.35, down -7.34% from its previous closing price of $0.37. In other words, the price has decreased by -$7.34 from its previous closing price. On the day, 2.18 million shares were traded. SEEL stock price reached its highest trading level at $0.3844 during the session, while it also had its lowest trading level at $0.2996.

Ratios:

To gain a deeper understanding of SEEL’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 0.08 and its Current Ratio is at 0.08.

Upgrades & Downgrades

In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, ROTH Capital on September 27, 2021, Upgraded its rating to Buy and sets its target price to $8 from $2.50 previously.

On July 01, 2021, Guggenheim started tracking the stock assigning a Buy rating and target price of $8.

On June 01, 2021, Cantor Fitzgerald started tracking the stock assigning a Overweight rating and target price of $10.Cantor Fitzgerald initiated its Overweight rating on June 01, 2021, with a $10 target price.

Insider Transactions:

Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Nov 30 ’23 when Golembiewski Michael Joseph bought 83,000 shares for $1.21 per share. The transaction valued at 100,222 led to the insider holds 86,450 shares of the business.

Mehra Raj bought 75,757 shares of SEEL for $99,999 on Dec 01 ’23. The insider now owns 185,142 shares after completing the transaction at $1.32 per share.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, SEEL now has a Market Capitalization of 988622 and an Enterprise Value of 12085521. As of this moment, Seelos’s Price-to-Earnings (P/E) ratio for their current fiscal year is 0.03. For the stock, the TTM Price-to-Sale (P/S) ratio is 1.03. Its current Enterprise Value per Revenue stands at 6.001.

Stock Price History:

Over the past 52 weeks, SEEL has reached a high of $300.00, while it has fallen to a 52-week low of $0.22. The 50-Day Moving Average of the stock is -37.74%, while the 200-Day Moving Average is calculated to be -95.60%.

Shares Statistics:

It appears that SEEL traded 1.88M shares on average per day over the past three months and 8686950 shares per day over the past ten days. A total of 5.96M shares are outstanding, with a floating share count of 5.65M. Insiders hold about 5.20% of the company’s shares, while institutions hold 3.58% stake in the company. Shares short for SEEL as of 1722384000 were 145378 with a Short Ratio of 0.08, compared to 1719532800 on 136114. Therefore, it implies a Short% of Shares Outstanding of 145378 and a Short% of Float of 5.1499999999999995.

Most Popular